Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. May 15, 2025; 17(5): 102459
Published online May 15, 2025. doi: 10.4251/wjgo.v17.i5.102459
Published online May 15, 2025. doi: 10.4251/wjgo.v17.i5.102459
Table 2 Univariate Cox regression analysis for cancer-specific survival and overall survival in stage IV pancreatic cancer patients
Variables | OS | CSS | ||
HR (95%CI) | P value | HR (95%CI) | P value | |
Age (years) | ||||
< 60 | 1 (reference) | 1 (reference) | ||
60-75 | 1.26 (1.10, 1.45) | 0.001 | 1.25 (1.08, 1.44) | 0.002 |
> 75 | 1.70 (1.44, 2.02) | < 0.001 | 1.71 (1.44, 2.03) | < 0.001 |
Sex | ||||
Female | 1 (reference) | 1 (reference) | ||
Male | 0.97 (0.87, 1.09) | 0.645 | 0.98 (0.87, 1.10) | 0.730 |
Race | ||||
White | 1 (reference) | 1 (reference) | ||
Black | 1.26 (1.03, 1.54) | 0.024 | 1.20 (0.98, 1.48) | 0.078 |
Other | 0.88 (0.72, 1.07) | 0.195 | 0.89 (0.73, 1.08) | 0.237 |
Marital status | ||||
Married | 1 (reference) | 1 (reference) | ||
Unmarried | 1.17 (0.99, 1.38) | 0.069 | 1.16 (0.98, 1.38) | 0.079 |
Divorced | 1.54 (1.34, 1.77) | < 0.001 | 1.52 (1.32, 1.76) | < 0.001 |
Unknown | 1.72 (1.28, 2.33) | < 0.001 | 1.71 (1.26, 2.32) | 0.001 |
Tumor location | ||||
Head | 1 (reference) | 1 (reference) | ||
Body | 1.34 (1.13, 1.60) | 0.001 | 1.35 (1.13, 1.61) | 0.001 |
Tail | 1.20 (1.02, 1.41) | 0.027 | 1.22 (1.03, 1.43) | 0.020 |
Other | 1.42 (1.22, 1.64) | < 0.001 | 1.42 (1.22, 1.65) | < 0.001 |
T stage | ||||
T1/T2 | 1 (reference) | 1 (reference) | ||
T3 | 0.76 (0.65, 0.89) | < 0.001 | 0.77 (0.66, 0.90) | 0.001 |
T4 | 0.92 (0.77, 1.09) | 0.339 | 0.93 (0.78, 1.11) | 0.413 |
TX | 1.13 (0.96, 1.35) | 0.148 | 1.10 (0.92, 1.31) | 0.288 |
N stage | ||||
N0 | 1 (reference) | 1 (reference) | ||
N1 | 0.96 (0.84, 1.09) | 0.488 | 0.98 (0.86, 1.12) | 0.789 |
NX | 1.44 (1.22, 1.69) | < 0.001 | 1.42 (1.20, 1.68) | < 0.001 |
Grade | ||||
Grade I/II | 1 (reference) | 1 (reference) | ||
Grade III/IV | 1.68 (1.37, 2.05) | < 0.001 | 1.69 (1.38, 2.08) | < 0.001 |
Unknown | 1.74 (1.48, 2.04) | < 0.001 | 1.72 (1.46, 2.02) | < 0.001 |
Surgery | ||||
No | 1 (reference) | 1 (reference) | ||
Yes | 0.46 (0.38, 0.56) | < 0.001 | 0.47 (0.38, 0.57) | < 0.001 |
Chemotherapy | ||||
No | 1 (reference) | 1 (reference) | ||
Yes | 0.33 (0.30, 0.38) | < 0.001 | 0.34 (0.30, 0.38) | < 0.001 |
Radiotherapy | ||||
No | 1 (reference) | 1 (reference) | ||
Yes | 0.76 (0.60, 0.97) | 0.027 | 0.78 (0.61, 0.99) | 0.040 |
Bone metastasis | ||||
No | 1 (reference) | 1 (reference) | ||
Yes | 1.10 (0.88, 1.37) | 0.397 | 1.15 (0.92, 1.44) | 0.206 |
Liver metastasis | ||||
No | 1 (reference) | 1 (reference) | ||
Yes | 1.49 (1.32, 1.68) | < 0.001 | 1.50 (1.32, 1.70) | < 0.001 |
Lung metastasis | ||||
No | 1 (reference) | 1 (reference) | ||
Yes | 1.02 (0.89, 1.17) | 0.819 | 1.01 (0.88, 1.16) | 0.910 |
- Citation: Huang K, Chen Z, Yuan XZ, He YS, Lan X, Du CY. Development and validation of machine learning nomograms for predicting survival in stage IV pancreatic cancer: A retrospective study. World J Gastrointest Oncol 2025; 17(5): 102459
- URL: https://www.wjgnet.com/1948-5204/full/v17/i5/102459.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i5.102459